Novel pretargeted radionuclide therapy for HER2-expressing cancers shows promise
Credit: Uppsala University, Uppsala, Sweden RESTON, VA - In a mouse model, researchers have demonstrated that a novel, affibody-based pretargeted radionuclide therapy for HER2 (human...